Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Mignot and Yanagisawa win Lasker prize for discovery of the role of orexins in wake, sleep, and narcolepsy
Clifford B. Saper
Clifford B. Saper
View: Text | PDF
Viewpoint

Mignot and Yanagisawa win Lasker prize for discovery of the role of orexins in wake, sleep, and narcolepsy

  • Text
  • PDF
Abstract

Authors

Clifford B. Saper

×

Figure 1

Molecular pharmacology of orexin action.

Options: View larger image (or click on image) Download as PowerPoint
Molecular pharmacology of orexin action.
(A) A schematic drawing showing...
(A) A schematic drawing showing the location of the orexin neurons in the lateral hypothalamus and the loss of orexin neurons in a patient with type 1 narcolepsy. (B) Shows a schematic view of the orexin gene, which contains the sequences for both the orexin A and orexin B peptides. Orexin A acts on both receptors, OX1R and OX2R, but orexin B acts mainly on OX2R. OX2R has been associated mainly with wake-sleep regulation and OX1R with reward seeking and addiction behavior. Dual orexin receptor antagonists are being used clinically to treat insomnia, but specific OX1R antagonists are under development to treat addiction and OX2R agonists are being tested for treating type 1 narcolepsy and may be useful in other disorders of increased daytime sleepiness. Adapted with permission from the New England Journal of Medicine (12).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts